Physician profile
Joseph Melrose
NPI 1740629153
$5,504.82
in general payments reported to CMS, 2019-2025
34 companies · $76.90 in 2025
The $76.90 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,679 · 2020: $2,065 · 2021: $501 · 2022: $120 · 2023: $45.35 · 2024: $17.60 · 2025: $76.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,408.82 | 2019-2020 | |
| Nevro Corp. | $637.54 | 2019-2022 | |
| Vertos Medical, INC. | $489.78 | 2019-2020 | |
| Amgen INC. | $333.79 | 2019-2020 | |
| Medtronic, INC. | $297.28 | 2021 | |
| Relievant Medsystems, INC. | $208.71 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $185.67 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.68 | 2019-2020 | |
| Allergan, INC. | $155.90 | 2019-2020 | |
| Lilly USA, LLC | $150.06 | 2019-2020 | |
| Almatica Pharma LLC | $139.80 | 2020 | |
| Biodelivery Sciences International, INC. | $130.14 | 2019 | |
| Mdd US Operations, LLC | $126.60 | 2019-2020 | |
| Boston Scientific Corporation | $111.53 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $105.61 | 2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $104.44 | 2019 | |
| Pfizer INC. | $91.47 | 2019-2020 | |
| Pacira Therapeutics, INC. | $73.51 | 2019 | |
| Collegium Pharmaceutical, INC. | $70.24 | 2019-2020 | |
| Haemonetics Corporation | $55.53 | 2024-2025 | Teg6s Hemostasis System |
| Radius Health, INC. | $54.84 | 2019-2020 | |
| Zyla Life Sciences, INC. | $53.18 | 2020 | |
| West Therapeutics Development, LLC | $44.18 | 2020 | |
| Fidia Pharma USA INC. | $43.25 | 2019-2020 | |
| Becton, Dickinson and Company | $38.97 | 2025 | Hemosphere |
| Hemosonics LLC | $29.41 | 2023 | Quantra Qplus System |
| Horizon Therapeutics Plc | $28.09 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $28.09 | 2020 | |
| Redhill Biopharma INC. | $26.96 | 2020 | |
| Daiichi Sankyo INC. | $26.81 | 2019 | |
| Abbott Laboratories | $24.80 | 2020 | |
| Vertical Pharmaceuticals, LLC | $24.33 | 2019 | |
| Sentynl Therapeutics, INC. | $22.87 | 2019 | |
| Merck Sharp & Dohme LLC | $15.94 | 2023 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Melrose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.